Methenamine Hippurate Tablet
Product Images NDC 47781-577

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Methenamine Hippurate (NDC 47781-577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alvogen Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Methenamine Structural Formula (52450d09 B77d 4bae 8d21 6394408e3f88 01)

Chemical structure of Methenamine Hippurate, showing the molecular arrangement of methenamine and hippurate components.*

FDA Label Image

Label (Label)

Methenamine Hippurate Tablets 1 g oral tablets label from Alvogen Inc., containing 100 tablets. The label includes dosage information, storage instructions in a light-resistant container below 30°C, and identifies it as a bulk package. The product is distributed by Alvogen, Inc., Pine Brook, NJ, and produced in France.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.